论文部分内容阅读
目的:研究重组人表皮生长因子对口腔颌面部外伤创面的治疗效果。方法:将2015年3月到2016年9月期间于我院接受治疗的颌面部软组织损伤患者100例作为研究对象,将其按照治疗方法的不同分为对照组和试验组。给予对照组患者油纱条敷于创面的方式进行治疗,试验组采用重组人表皮生长因子进行治疗。结果:试验组患者的创面平均愈合时间较对照组明显更短,两组数据相比P<0.05。并且试验组患者的癜痕发生率低于对照组,两组数据相比P<0.05。结论:重组人表皮生长因子对口腔颌面部外伤创面的疗效显著,具有较高临床推广价值。
Objective: To study the therapeutic effect of recombinant human epidermal growth factor on oral and maxillofacial wounds. Methods: 100 cases of maxillofacial soft tissue injury treated in our hospital from March 2015 to September 2016 were divided into control group and experimental group according to different treatment methods. Patients in the control group were treated with oil gauze spread on the wounds. The experimental group was treated with recombinant human epidermal growth factor. Results: The wound healing time was significantly shorter in the test group than in the control group, P <0.05 compared with the two groups. And the incidence of purgatory in the test group was lower than that in the control group, P <0.05 compared with the two groups. Conclusion: The recombinant human epidermal growth factor has a significant therapeutic effect on oral and maxillofacial wounds and has a high clinical value.